{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:24Z","timestamp":1786982844152,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["No. 2020JJ4888"],"award-info":[{"award-number":["No. 2020JJ4888"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02550-3","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T04:45:28Z","timestamp":1739421928000},"page":"1317-1331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p\/SREBP1 axis"],"prefix":"10.1007","volume":"48","author":[{"given":"Zilan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiating","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2550_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020 (2021) GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA-Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA-Cancer J Clin"},{"key":"2550_CR2","doi-asserted-by":"publisher","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S (2022) The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 10:264\u2013272. https:\/\/doi.org\/10.1016\/S2213-8587(22)00035","DOI":"10.1016\/S2213-8587(22)00035"},{"key":"2550_CR3","doi-asserted-by":"publisher","unstructured":"Chen DW, Lang B, McLeod D, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401:1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X","DOI":"10.1016\/S0140-6736(23)00020-X"},{"key":"2550_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","volume":"23","author":"JA Fagin","year":"2023","unstructured":"Fagin JA, Krishnamoorthy GP, Landa I (2023) Pathogenesis of cancers derived from thyroid follicular cells. Nat Rev Cancer 23:631\u2013650. https:\/\/doi.org\/10.1038\/s41568-023-00598-y","journal-title":"Nat Rev Cancer"},{"key":"2550_CR5","doi-asserted-by":"publisher","first-page":"215581","DOI":"10.1016\/j.canlet.2022.215581","volume":"532","author":"C Miro","year":"2022","unstructured":"Miro C, Di Giovanni A, Murolo M, Cicatiello AG, Nappi A, Sagliocchi S, Di Cicco E, Morra F, Celetti A, Pacifico F, Imbimbo C, Crocetto F, Dentice M (2022) Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Lett 532:215581. https:\/\/doi.org\/10.1016\/j.canlet.2022.215581","journal-title":"Cancer Lett"},{"key":"2550_CR6","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0228","author":"S Torabinejad","year":"2023","unstructured":"Torabinejad S, Miro C, Barone B, Imbimbo C, Crocetto F, Dentice M (2023) The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications. Eur Thyroid J. https:\/\/doi.org\/10.1530\/ETJ-22-0228","journal-title":"Eur Thyroid J"},{"key":"2550_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","volume":"43","author":"RA DeBose-Boyd","year":"2018","unstructured":"DeBose-Boyd RA, Ye J (2018) SREBPs in lipid metabolism, insulin signaling, and Beyond. Trends Biochem Sci 43:358\u2013368. https:\/\/doi.org\/10.1016\/j.tibs.2018.01.005","journal-title":"Trends Biochem Sci"},{"key":"2550_CR8","doi-asserted-by":"publisher","first-page":"109791","DOI":"10.1016\/j.biopha.2019.109791","volume":"123","author":"C Li","year":"2020","unstructured":"Li C, Peng X, Lv J, Zou H, Liu J, Zhang K, Li Z (2020) SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer. Biomed Pharmacother 123:109791. https:\/\/doi.org\/10.1016\/j.biopha.2019.109791","journal-title":"Biomed Pharmacother"},{"key":"2550_CR9","doi-asserted-by":"publisher","first-page":"769647","DOI":"10.3389\/fphar.2021.769647","volume":"12","author":"T Zhu","year":"2021","unstructured":"Zhu T, Wang Z, Zou T, Xu L, Zhang S, Chen Y, Chen C, Zhang W, Wang S, Ding Q, Xu G (2021) SOAT1 promotes gastric Cancer Lymph Node Metastasis through lipid synthesis, front. Pharmacol 12:769647. https:\/\/doi.org\/10.3389\/fphar.2021.769647","journal-title":"Pharmacol"},{"key":"2550_CR10","doi-asserted-by":"publisher","first-page":"174280","DOI":"10.1016\/j.ejphar.2021.174280","volume":"906","author":"H Meng","year":"2021","unstructured":"Meng H, Shen M, Li J, Zhang R, Li X, Zhao L, Huang G, Liu J (2021) Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis. Eur J Pharmacol 906:174280. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174280","journal-title":"Eur J Pharmacol"},{"key":"2550_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.toxlet.2021.05.006","volume":"348","author":"S Guo","year":"2021","unstructured":"Guo S, Zhang Y, Wang S, Yang T, Ma B, Li X, Zhang Y, Jiang X (2021) LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P\/SREBP1 signaling. Toxicol Lett 348:50\u201358. https:\/\/doi.org\/10.1016\/j.toxlet.2021.05.006","journal-title":"Toxicol Lett"},{"key":"2550_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/thy.2017.0330","volume":"28","author":"CM Beukhof","year":"2018","unstructured":"Beukhof CM, Massolt ET, Visser TJ, Korevaar T, Medici M, de Herder WW, Roeters VLJ, Mulder MT, de Rijke YB, Reiners C, Verburg FA, Peeters RP (2018) Effects of Thyrotropin on Peripheral thyroid hormone metabolism and serum lipids. Thyroid 28:168\u2013174. https:\/\/doi.org\/10.1089\/thy.2017.0330","journal-title":"Thyroid"},{"key":"2550_CR13","doi-asserted-by":"publisher","unstructured":"Wang F, Tan Y, Wang C, Zhang X, Zhao Y, Song X, Zhang B, Guan Q, Xu J, Zhang J, Zhang D, Lin H, Yu C, Zhao J (2012) Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. J Clin Endocrinol Metab 97:2724\u20132731. https:\/\/doi.org\/10.1210\/jc.2012","DOI":"10.1210\/jc.2012"},{"key":"2550_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-022-01199-1","volume":"7","author":"X Zhou","year":"2022","unstructured":"Zhou X, Huang F, Ma G, Wei W, Wu N, Liu Z (2022) Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis. Signal Transduct Target Ther 7:370. https:\/\/doi.org\/10.1038\/s41392-022-01199-1","journal-title":"Signal Transduct Target Ther"},{"key":"2550_CR15","doi-asserted-by":"publisher","unstructured":"Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4","DOI":"10.1038\/sigtrans.2015.4"},{"key":"2550_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME, MicroRNA J (2018) Allergy Clin Immunol 141:1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"Allergy Clin Immunol"},{"key":"2550_CR17","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1128\/JVI.03022-12","volume":"87","author":"T Shirasaki","year":"2013","unstructured":"Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S (2013) MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J Virol 87:5270\u20135286. https:\/\/doi.org\/10.1128\/JVI.03022-12","journal-title":"J Virol"},{"key":"2550_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-021-01943-5","volume":"40","author":"J Shi","year":"2021","unstructured":"Shi J, Yang C, An J, Hao D, Liu C, Liu J, Sun J, Jiang J (2021) KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. J Exp Clin Cancer Res 40:148. https:\/\/doi.org\/10.1186\/s13046-021-01943-5","journal-title":"J Exp Clin Cancer Res"},{"key":"2550_CR19","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1002\/1878-0261.13045","volume":"15","author":"A Wambecke","year":"2021","unstructured":"Wambecke A, Ahmad M, Morice PM, Lambert B, Weiswald LB, Vernon M, Vigneron N, Abeilard E, Brotin E, Figeac M, Gauduchon P, Poulain L, Denoyelle C, Meryet-Figuiere M (2021) The lncRNA \u2018UCA1\u2019 modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels. Mol Oncol 15:3659\u20133678. https:\/\/doi.org\/10.1002\/1878-0261.13045","journal-title":"Mol Oncol"},{"key":"2550_CR20","doi-asserted-by":"publisher","first-page":"110326","DOI":"10.1016\/j.cellsig.2022.110326","volume":"94","author":"W Chen","year":"2022","unstructured":"Chen W, Tan X, Yang Q, Fang Z, Xu Y (2022) MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p\/PBOV1 axis. Cell Signal 94:110326. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110326","journal-title":"Cell Signal"},{"key":"2550_CR21","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.21873\/anticanres.16639","volume":"43","author":"J Zhou","year":"2023","unstructured":"Zhou J, Liu J, Zhang KE, Lv J, Peng X, Liu J, Li Z (2023) High-throughput sequencing analysis of differentially expressed microRNAs Associated with SREBP1 in differentiated thyroid carcinoma. Anticancer Res 43:4435\u20134446. https:\/\/doi.org\/10.21873\/anticanres.16639","journal-title":"Anticancer Res"},{"key":"2550_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME, Cancer T, Review A (2024) JAMA-J Am Med Assoc 331:425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA-J Am Med Assoc"},{"key":"2550_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/thy.2010.0021","volume":"21","author":"B Aschebrook-Kilfoy","year":"2011","unstructured":"Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS (2011) Thyroid cancer incidence patterns in the United States by histologic type, 1992\u20132006. Thyroid 21:125\u2013134. https:\/\/doi.org\/10.1089\/thy.2010.0021","journal-title":"Thyroid"},{"key":"2550_CR24","doi-asserted-by":"publisher","unstructured":"Wang Z, Ji G, Wu Q, Feng S, Zhao Y, Cao Z, Tao C (2018) Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1, Life Sci. 210:263\u2013270. https:\/\/doi.org\/10.1016\/j.lfs.2018.08.043","DOI":"10.1016\/j.lfs.2018.08.043"},{"key":"2550_CR25","doi-asserted-by":"publisher","unstructured":"Zhang LY, Chen Y, Jia J, Zhu X, He Y, Wu LM (2019) MiR-27a promotes EMT in ovarian cancer through active Wnt\/\ud737-catenin signalling by targeting FOXO1, Cancer Biomark. 24:31\u201342. https:\/\/doi.org\/10.3233\/CBM-181229","DOI":"10.3233\/CBM-181229"},{"key":"2550_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.10.025","author":"F Jin","year":"2019","unstructured":"Jin F, Yang R, Wei Y, Wang D, Zhu Y, Wang X, Lu Y, Wang Y, Zen K, Li L (2019) HIF-1alpha-induced miR-23a approximately 27a approximately 24 cluster promotes colorectal cancer progression via reprogramming metabolism. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2018.10.025","journal-title":"Cancer Lett"},{"key":"2550_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.breast.2018.10.007","volume":"43","author":"B Ljepoja","year":"2019","unstructured":"Ljepoja B, Garcia-Roman J, Sommer AK, Wagner E, Roidl A (2019) MiRNA-27a sensitizes breast cancer cells to treatment with selective estrogen receptor modulators. Breast 43:31\u201338. https:\/\/doi.org\/10.1016\/j.breast.2018.10.007","journal-title":"Breast"},{"key":"2550_CR28","first-page":"405","volume":"7","author":"F Wu","year":"2017","unstructured":"Wu F, Li J, Guo N, Wang XH, Liao YQ (2017) MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt\/beta-catenin signaling pathway. Am J Cancer Res 7:405\u2013416","journal-title":"Am J Cancer Res"},{"key":"2550_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-018-0431-2","volume":"9","author":"F Fang","year":"2018","unstructured":"Fang F, Huang B, Sun S, Xiao M, Guo J, Yi X, Cai J, Wang Z (2018) miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-betaRI signaling pathway. Cell Death Dis 9:395. https:\/\/doi.org\/10.1038\/s41419-018-0431-2","journal-title":"Cell Death Dis"},{"key":"2550_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/or.2013.2807","volume":"31","author":"L Zhu","year":"2014","unstructured":"Zhu L, Wang Z, Fan Q, Wang R, Sun Y (2014) microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncol Rep 31:280\u2013286. https:\/\/doi.org\/10.3892\/or.2013.2807","journal-title":"Oncol Rep"},{"key":"2550_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.biocel.2016.08.043","volume":"79","author":"X Wan","year":"2016","unstructured":"Wan X, Huang W, Yang S, Zhang Y, Zhang P, Kong Z, Li T, Wu H, Jing F, Li Y (2016) Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression. Int J Biochem Cell Biol 79:249\u2013260. https:\/\/doi.org\/10.1016\/j.biocel.2016.08.043","journal-title":"Int J Biochem Cell Biol"},{"key":"2550_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JME-19-0159","volume":"64","author":"X Che","year":"2020","unstructured":"Che X, Jian F, Chen C, Liu C, Liu G, Feng W (2020) PCOS serum-derived exosomal miR-27a-5p stimulates endometrial cancer cells migration and invasion. J Mol Endocrinol 64:1\u201312. https:\/\/doi.org\/10.1530\/JME-19-0159","journal-title":"J Mol Endocrinol"},{"key":"2550_CR33","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1172\/JCI127201","volume":"129","author":"Y Cao","year":"2019","unstructured":"Cao Y (2019) Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest 129:3006\u20133017. https:\/\/doi.org\/10.1172\/JCI127201","journal-title":"J Clin Invest"},{"key":"2550_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/iub.2421","volume":"73","author":"A Rafiei","year":"2021","unstructured":"Rafiei A, Ferns GA, Ahmadi R, Khaledifar A, Rahimzadeh-Fallah T, Mohmmad-Rezaei M, Emami S, Bagheri N (2021) Expression levels of miR-27a, miR-329, ABCA1, and ABCG1 genes in peripheral blood mononuclear cells and their correlation with serum levels of oxidative stress and hs-CRP in the patients with coronary artery disease. IUBMB Life 73:223\u2013237. https:\/\/doi.org\/10.1002\/iub.2421","journal-title":"IUBMB Life"},{"key":"2550_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","volume":"22","author":"P Agbu","year":"2021","unstructured":"Agbu P, Carthew RW (2021) MicroRNA-mediated regulation of glucose and lipid metabolism. Nat Rev Mol Cell Biol 22:425\u2013438. https:\/\/doi.org\/10.1038\/s41580-021-00354-w","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2550_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOL.0000000000000420","volume":"28","author":"B Aryal","year":"2017","unstructured":"Aryal B, Singh AK, Rotllan N, Price N, Fernandez-Hernando C (2017) MicroRNAs and lipid metabolism. Curr Opin Lipidol 28:273\u2013280. https:\/\/doi.org\/10.1097\/MOL.0000000000000420","journal-title":"Curr Opin Lipidol"},{"key":"2550_CR37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.ygeno.2018.08.004","volume":"111","author":"M Ma","year":"2019","unstructured":"Ma M, Yin Z, Zhong H, Liang T, Guo L (2019) Analysis of the expression, function, and evolution of miR-27 isoforms and their responses in metabolic processes. Genomics 111:1249\u20131257. https:\/\/doi.org\/10.1016\/j.ygeno.2018.08.004","journal-title":"Genomics"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02550-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:50:29Z","timestamp":1751521829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02550-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02550-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known financial interests or personal relationships that might influence the work reported here.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}